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a b s t r a c t
Topoisomerases modulate the topological state of DNA during processes, such as replication and
transcription, that cause overwinding and/or underwinding of the DNA. African swine fever virus
(ASFV) is a nucleo–cytoplasmic double-stranded DNA virus shown to contain an OFR (P1192R) with
homology to type II topoisomerases. Here we observed that pP1192R is highly conserved among ASFV
isolates but dissimilar from other viral, prokaryotic or eukaryotic type II topoisomerases. In both ASFV/
Ba71V-infected Vero cells and ASFV/L60-infected pig macrophages we detected pP1192R at intermediate
and late phases of infection, cytoplasmically localized and accumulating in the viral factories. Finally, we
used a Saccharomyces cerevisiae temperature-sensitive strain in order to demonstrate, through
complementation and in vitro decatenation assays, the functionality of P1192R, which we further
conﬁrmed by mutating its predicted catalytic residue. Overall, this work strengthens the idea that
P1192R constitutes a target for studying, and possibly controlling, ASFV transcription and replication.
& 2014 Elsevier Inc. All rights reserved.
Introduction
African swine fever (ASF) is a highly threatening disease for pig
husbandry, against which there is neither effective vaccine nor
treatment. The etiological agent, the African swine fever virus
(ASFV), is an icosahedral nucleo–cytoplasmic double-stranded
DNA arbovirus, the only member of the family Asfarviridae
(Dixon et al., 2012). ASFV can be transmitted either directly
through contact between infected and susceptible animals or
indirectly through virus contaminated feed or fomites (EFSA
AHAW Panel, 2014). ASFV can also be transmitted by soft ticks of
the genus Ornithodoros, which are of particular relevance in sub-
Saharan endemic countries (Costard et al., 2013) and acted as long
term reservoirs during ASFV endemicity in the Iberian Peninsula
(Basto et al., 2006). While its natural mammalian hosts, the
bushpig and the warthog, show no clinical signs upon infection,
in other members of the family Suidae, like the domestic pig, the
disease may vary from chronic and unapparent to acute and
deadly clinical forms (Blome et al., 2013). Similarly to other
nucleo–cytoplasmic large DNA viruses (NCLDV), or as proposed
recently, members of the Megavirales order (Colson et al., 2013),
the ASFV genome codes, or is predicted to code, for several
proteins involved in replicative and transcriptional phenomena
(Dixon et al., 2013) including a putative protein with homology to
type II DNA topoisomerases (Baylis et al., 1992; García-Beato et al.,
1992).
DNA topoisomerases are enzymes that modulate the topologi-
cal state of DNA molecules. They are essential in processes such as
DNA replication, recombination, repair and transcription that
cause overwinding and/or underwinding of the DNA which, if
not resolved, may compromise genomic stability and cellular
viability. Topoisomerases are classiﬁed into two classes: type I
topoisomerases (topoI) are ATP-independent enzymes that pro-
duce transient single-stranded breaks in the DNA molecule,
thereby facilitating the unwinding and changing the topological
linking number by steps of one. Type II topoisomerases (topoII)
require ATP in order to transiently cleave both strands of DNA
which, followed by double-stranded DNA passage, changes the
linking number by steps of two (Wang, 2002). Therefore, type II
topoisomerases have the ability to resolve knots and tangles in the
DNA, and allow for the segregation of intertwined DNA molecules
following replication. In lower eukaryotes, like Saccharomyces
cerevisiae, type II topoisomerases are represented by a single
isoform (Goto and Wang, 1984), while higher eukaryotes and
bacteria encode two forms of these enzymes. DNA gyrase and
topoisomerase IV are closely related enzymes that can be found in
bacteria, but despite being closely related, their physiological roles
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are distinct (Anderson and Osheroff, 2001). In vertebrates, two
highly identical type II topoisomerases also exist, topoisomerase
IIα and IIβ, and while their mechanism of action seems to be equal,
they diverge in their expression pattern throughout the cell cycle
and in their tissue distribution, suggesting that their cellular roles
are different (Nitiss, 2009). In viruses, while type I topoisomerases
are coded by families Poxviridae and Mimiviridae (Forterre and
Gadelle, 2009), type II topoisomerases are identiﬁed in several
NCLDV families, such as Iridoviridae, Asfarviridae, Mimiviridae and
Phycodnaviridae (Iyer et al., 2001; Yutin et al., 2013), as well as in
bacteriophages of the T4 superfamily (Kreuzer, 1998). Hitherto, the
only known mammalian-infecting virus that putatively codes for a
type II topoisomerase is ASFV (Baylis et al., 1992; García-Beato
et al., 1992), and since it has a rather large linear genome, varying
from 170 to 190 kbp depending on the isolate, and contains
terminal inverted repeats and covalently closed ends (González
et al., 1986), a type II topoisomerase may indeed be necessary for
viral replication and/or transcriptional events. In this work we
show that ORF P1192R codes for a protein highly conserved among
ASFV isolates, though divergent from other known type II topoi-
somerases, which is detectable in infected cells from intermediate
to late phases of infection. Importantly, we demonstrate that
P1192R codes for a functional type II DNA topoisomerase, opening
new perspectives for the study of ASFV transcription and
replication.
Results
P1192R structurally resembles a type II topoisomerase
Eukaryotic type II topoisomerases are typically composed of an
N-terminal ATP-binding domain, a central catalytic domain and a
C-terminal regulatory domain (Champoux, 2001). After determin-
ing the nucleotide sequence for ORF P1192R from ASFV isolate L60
(GenBank accession: KM261522), our bioinformatic analysis on the
deduced amino acid sequence showed that the depicted organiza-
tion is fairly conserved, but in this particular case the C-terminal
domain is missing, with the central domain extending up to the
end of the protein sequence (Fig. 1). Searching P1192R for amino
acid motifs which have been described as being highly conserved
among type II topoisomerases, such as RPXXYIGS, GXGXP,
GGXXGXG, EGDSA, PL(R/K)GK(I/L/M)LNV, IM(T/A)D(Q/A)DXD and
YKGLG (Austin and Marsh, 1998), we found only matches for some,
namely GPGIP, GGTNGVG (which includes the predicted ATP-
binding site, shown underlined) and EGDSA. In addition, using
PRINTS to search for conserved motifs we found nine N-terminal
conserved motifs, in which the above mentioned three are
included, and 11 motifs recognized as “eukaryotic-type”, distrib-
uted throughout the central domain of the protein and aligning
extremely well with those identiﬁed through the same method for
other type II topoisomerases, like topoIIα from Homo sapiens or
topoII from the Paramecium bursaria Chlorella virus Marburg 1
(not shown). The predicted catalytic residue for P1192R is a
tyrosine at position 800, contained in the motif SPRYI which is
conserved among eukaryotic type II topoisomerases. We also
found a putative NLS at positions 293–299 (PKFKKFE), using the
PSORT II program, as well as a putative NES at residues 443–452
(LSLLRTGLTL), predicted by the NetNES 1.1 program.
P1192R is conserved among ASFV isolates
Several ASFV isolates of different virulence and geographic
origin have had their genome fully sequenced. Therefore, we
compared the DNA sequence of ORF P1192R from L60 isolate to
that of 13 other ASFV isolates. In the analyzed genomes, ORF
P1192R is composed by 3579 nucleotides, with the E75 isolate
being the exception, in which the annotated P1192R ORF has only
3434 nucleotides. When looking at the nucleotide sequence of
P1192R in E75, a nucleotide is missing at position 2176 (numbering
relates to the other 13 P1192R sequences), which leads to a
frameshift, and, at position 3443, there is an extra nucleotide,
which restores the original frame of the ORF via another frame-
shift. Since the frameshifts mentioned above originate in stretches
of G's and A's, respectively, and because at positions 1491 and
1492 of the E75 sequence two N's can be found, we assumed that
the E75 sequence from the database contains errors. To clarify this,
ORF P1192R from E75 was sequenced and found to be identical to
the sequence obtained for L60 and to the sequence available for
Ba71V (not shown).
Using the E75-corrected sequence, we aligned the 14 P1192R
DNA sequences manually, since their length was identical. We
used this alignment to perform a maximum likelihood phyloge-
netic analysis, and the phylogenetic tree obtained (Fig. 2A)
strongly resembles that of the p72 genotyping (Gallardo et al.,
2009). The isolates are separated into three clusters, with one
main cluster including the ﬁve isolates from the Iberian Peninsula
and the Benin97/1 from Western Africa, together with one isolate
from South Africa (Mkuzi1979), while another cluster consisted of
four isolates from the Eastern (Tengani62) and Southern (Pretor-
isuskop96/4; Warmbaths; Warthog) African regions together with
the recently described Georgia2007/1 isolate, which curiously
branched in this latter cluster in opposition to the p72 genotype
tree. A third and smaller cluster contained the Kenya1950 and
Malawi Lil/20/1 isolates, derived from the Eastern part of Africa,
and given their genetic differences, this cluster ended up working
as an outgroup.
An analysis of the deduced P1192R amino acid sequences from
the various isolates resulted in a similar tree topology (Fig. 2B)
with minor differences. The Pretorisuskop96/4 isolate is not clearly
separated from the Warmbaths and Warthog isolates, and the
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Fig. 1. Identiﬁcation of functional motifs and domains in the amino acid sequence of P1192R. The upper scheme indicates the type II DNA topoisomerase speciﬁc domains
found in the predicted amino acid sequence of P1192R, as well as potential functional and regulatory motifs. These include the ATP-binding site (GTNGVG at positions 142–
147), the quinolone-resistance determining region (EGDSA at positions 438–442) and the catalytic residue (Y at position 800), as well as putative NLS (PKFKKFE at positions
293–299) and NES (LSLLRTGLTL at positions 443–452) motifs. The lower scheme indicates domains of P1192R homologous to its bacterial counterparts gyraseB (N-terminal)
and gyraseA (C-terminal).
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Georgian isolate is now branching closer to the genotype I isolates
as seen for p72 genotyping.
Both phylogenetic trees reﬂect what is observed in terms of
identity between the 14 sequences analyzed (see Supplementary
ﬁle 1). While sequences from the European isolates are 100%
identical and highly similar to the West African Benin97/1 isolate,
variation is observed among isolates from the Southern and
Eastern regions of Africa.
P1192R is a distinctive type II topoisomerase
We also addressed the resemblance of P1192R to other known
viral type II topoisomerases. Using the P1192R protein sequence as
bait, we performed a protein-protein BLAST (BlastP) search to ﬁnd
similar enzymes in other viruses. We did not obtain many hits, and
most are from closely related viruses. Those which are known to
encode type II topoisomerases are all large DNA viruses, as is the
case of ASFV, infecting a wide range of hosts, from prokaryotic to
eukaryotic organisms, although none of them infects mammals. In
the phylogenetic tree resulting from the comparison of these
sequences (Fig. 3) P1192R from L60 clusters with the topoII from
phage T4 (composed by three different subunits but, for the
purpose of this study, we concatenated the three sequences in
order to yield a comparable topoII sequence), even though their
difference is high as denoted by the branch lengths. The topoII
from phage T4 is actually the sequence to which P1192R is less
identical, and it has higher identity with sequence from algae-
infecting viruses (see Fig. 3).
Finally, we wanted to know how P1192R would ﬁt in a broader
picture of DNA topoisomerases. For this, we added to our compar-
ison sequences from well-known and less-known topoII, as well as
type I topoisomerases sequences which we expected to act as an
outgroup, and we performed a new phylogenetic analysis. In the
phylogenetic tree obtained (Fig. 4) there is a clear separation
between vertebrates and the remaining eukaryotes and, curiously,
there is also a closer proximity of viral topoII with those from
intracellular parasitic organisms. L60 P1192R branches in this
latter cluster, but with considerable branch length, and it is
somewhat bridging prokaryotic and eukaryotic topoII, indicating
that it is highly divergent from known type II topoisomerases.
pP1192R is a cytoplasmic protein
To assess the cellular localization of pP1192R, we constructed
a GFP-P1192R fusion protein and analyzed its localization by
ﬂuorescence microscopy in COS-7 transfected cells. While cells
expressing GFP alone, used as controls, present a uniform staining
both in the cytoplasm and in the nucleus, we observed that GFP-
pP1192R is cytoplasmically distributed (Fig. 5A), with an apparent
nuclear exclusion. Since the virus may need its type II topoisome-
rase for early gene expression, and given the fact that viral
genomes are described as being present in the nucleus at early
times of infection (Ballester et al., 2010; Brookes et al., 1996; Caeiro
et al., 1990; Eulálio et al., 2007), we wanted to clarify if pP1192R
was indeed excluded from the nucleus. Additionally, our bioinfor-
matic analysis of P1192R identiﬁed putative nuclear localization
and nuclear export signals. Therefore, we independently deleted
these sequences in the GFP-P1192R fusion to test if the cellular
distribution of the resulting protein would change. However, none
of these deletions induced a shift in the localization of the fusion
protein, which remained cytoplasmic (Fig. 5A). In addition, we
performed a 3-hour treatment of GFP-pP1192R transfected cells
with leptomycin B, which speciﬁcally inhibits the CRM-1-
dependent nuclear export pathway, but the treatment did not
alter the observed localization of GFP-pP1192R, even though it led
to the nuclear accumulation of the p65 subunit of NF-κB, used as a
control (Fig. 5B).
Fig. 2. Phylogenetic analysis of ASFV P1192R. (A) Maximum-likelihood phylogenetic tree constructed from a multiple nucleotide sequence alignment of P1192R from 14
different ASFV isolates. (B) Maximum-likelihood phylogenetic tree constructed from a multiple amino acid sequence alignment of P1192R from 14 different ASFV isolates.
Values indicated between square brackets refer to percentage identity of the respective sequence to the L60 sequence. Bootstrap values are indicated in red.
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Fig. 3. Maximum-likelihood phylogenetic analysis of NCLDV type II topoisome-
rases. Maximum-likelihood phylogenetic tree was constructed from a multiple
amino acid sequence alignment of type II topoisomerases from NCLDV. Sequences
for variola and vaccinia viruses are from type I topoisomerases and work as an
outgroup. Values indicated between square brackets refer to percentage identity of
the respective sequence to the ASFV/L60 sequence. Bootstrap values are indicated
in red.
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Fig. 4. Maximum-likelihood phylogenetic analysis of type II topoisomerases from several domains of the tree of life. Maximum-likelihood phylogenetic tree was constructed
from a multiple amino acid sequence alignment of type II topoisomerases. Type I topoisomerases sequences work as an outgroup. The values between brackets denote the
number of sequences contained in the collapsed branches. For details on these collapsed sequences, see Supplementary ﬁle 3. Bootstrap values are indicated in red.
Fig. 5. Evaluation of the cellular distribution of GFP-pP1192R. (A) COS-7 cells were transfected with GFP, GFP-P1192R or respective mutant forms in which the sequences for
the putative nuclear localization signal or nuclear export signal were deleted (ΔNLS and ΔNES, respectively). (B) COS-7 cells were transfected with GFP-P1192R and, where
indicated, treated with 20 ng/ml leptomycin B (LMB) for 3 h. (C) COS-7 cells were transfected with GFP-P1192R, infected with the Ba71V isolate and analyzed at 4hpi and
8hpi. Where indicated, the cells were treated with leptomycin B (LMB) as in (B). In the merged panels, the GFP signal is shown in green, the anti-ASFV signal or the NF-κB
anti-p65 signal in red and DNA DAPI staining in blue. Representative microscopy images of at least two independent experiments are shown. A white arrowhead indicates an
example of a viral factory.
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pP1192R co-localizes with the viral factories
Considering that the cellular localization of pP1192R could be
inﬂuenced, or regulated, by other viral protein(s), or even by the
presence of viral DNA, we decided to infect COS-7 transfected cells
with Ba71V. At 4-hours post-infection (hpi), no change in the
cytoplasmic distribution of GFP-pP1192R was observed, and this
did not change after incubation with leptomycin B (Fig. 5C).
However, at 8hpi we observed a striking accumulation of GFP-
pP1192R in the viral factories, together with a reduction of the GFP
signal throughout the cytoplasm, implying that the recombinant
protein is recruited during infection. This recruitment remained
unaltered after leptomycin B incubation. Infection of COS-7 cells
transfected with GFP alone had no effect on the localization of the
ﬂuorescent protein (not shown).
This result prompted us to analyze the cellular localization of
viral pP1192R by immunoﬂuorescence, using an antiserum raised
against a full-length recombinant pP1192R which recognizes GFP-
pP1192R in COS-7 transfected cells (Fig. 6A). In Ba71V-infected
Vero cells pP1192R was detected as early as 6hpi, being present in
several cytoplasmic foci (Fig. 6B). At later times the protein
co-localized with and accumulated in viral factories, and was
never observed in the nucleus of the infected cells. Similar results
were observed in pig macrophages infected with L60 (Fig. 6C),
although, in this case, pP1192R was only detected after 8hpi,
already co-localizing with viral factories, where it accumulated
over the course of the infection. These results are in accordance
with García-Beato et al. (1992) who state that P1192R RNA is
mainly detected in the late phase of infection. However, these
authors also detected vestigial amounts of P1192R RNA after an 18-
h infection in the presence of cytosine arabinoside (AraC), which
inhibits viral DNA replication, suggesting that P1192R is tran-
scribed, even if at a very low level, in the early phase of infection.
Consequently, we performed immunoﬂuorescence studies in the
presence of AraC using Ba71V-infected Vero cells. At 4hpi no
difference is observed between AraC untreated and treated
infected-cells (Fig. 7A), with no detectable signs of pP1192R, while
at 16hpi pP1192R was clearly detected in untreated infected-cells
but remained undetectable in AraC-treated infected cells. The
effect of AraC upon Ba71V infection was monitored by expression
of a typical early ASFV protein, VP32, and of a late protein, VP72.
While in both untreated and treated Ba71V-infected cells VP32
was always detected (Fig. 7B), expression of VP72 was never
detected upon AraC treatment of infected cells (Fig. 7C).
pP1192R functionally complements a yeast top2 thermo-sensitive
mutation
Although we observed that P1192R codes for a protein
expressed during viral infection, it remained to be demonstrated
that pP1192R is indeed a functional type II topoisomerase. For this
purpose, ORF P1192R was cloned in the yeast expression plasmid
pYES2, under the control of the yeast GAL1 promoter. Transcription
from this promoter is strongly repressed in the presence of
Fig. 6. Cellular distribution of viral pP1192R during infection. (A) COS-7 cells were transfected with GFP or GFP-P1192R and analyzed by immunoﬂuorescence. In the merged
panels, the GFP-P1192R signal is shown in green, the anti-pP1192R signal in red and DNA DAPI staining in blue. (B) Vero cells were infected with Ba71V and analyzed by
immunoﬂuorescence at the indicated time-points. (C) Pig macrophages (Mφ) were infected with L60 and analyzed by immunoﬂuorescence at the indicated time-points. For
(B) and (C), in the merged panels the anti-ASFV signal is shown in green, the anti-pP1192R signal in red and DNA DAPI staining in blue. Representative microscopy images of
at least two independent experiments are shown. White arrowheads indicate examples of viral factories.
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glucose, but in the presence of galactose and in the absence of
glucose expression can be up-regulated up to 2000-fold (Maya
et al., 2008). This plasmid was then introduced in S. cerevisiae cells
of strain JCW26 (Wasserman et al., 1993), which contain a thermo-
sensitive mutation in TOP2 (top2 ts) that allows them to grow at
Fig. 7. Expression of viral proteins in the presence of AraC. Vero cells were infected
with Ba71V in the presence of 50 mg/ml of AraC and analyzed by immunoﬂuores-
cence at the indicated time-points. In the merged panels, the anti-ASFV signal is
shown in green, the anti-P1192R signal (A), the anti-VP32 signal (B) or the anti-
VP72 signal (C) in red and DNA DAPI staining in blue. Representative microscopy
images of three independent experiments are shown. White arrowheads indicate
examples of viral factories.
Fig. 8. Functional complementation of a yeast top2 temperature-sensitive mutation
by P1192R. (A) Yeast strain JCW26 was transformed with pYES2, pYES2-P1192R,
pYES2-P1192R-TOP2Cterm, pYES2-P1192R-TOP2Cterm Y800F, pYES2-TOP2Cterm or
pYES2-TOP2. Serial three-fold dilutions of each transformant were plated on YP
media containing glucose or galactose and incubated at either 25 1C or 35 1C. The
plates were photographed on the ﬁfth day of incubation. (B) Yeast cultures of
transformants as in (A) were diluted to a starting OD600 of 0.1 in galactose-
containing medium and then split in half and incubated at either 25 1C or 35 1C. The
graphic represents the mean (7 standard error) of the ratio between the OD600
values obtained at the indicated time-points for the cultures incubated at 35 1C and
the cultures incubated at 25 1C, for four different colonies for each transformant,
from three independent experiments. The asterisk marks results that are signiﬁ-
cantly different (po0.05) using a one-way analysis of variance (ANOVA) and post
hoc tests. (C) Yeast strain JCW26 was transformed with pYES2-GFP, pYES2-GFP-
P1192R or pYES2-P1192R-TOP2Cterm. Cultures of each transformant were diluted
to a starting OD600 of 0.5 in galactose-containing medium and incubated at 25 1C
for 16 h. In the merged panels, the GFP signal is shown in green and DNA DAPI
staining in blue. Experiments were performed at least twice and representative
images are shown.
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25 1C (permissive temperature), but makes Top2p non-functional
at 35 1C (restrictive temperature). We checked for functional
complementation of the pP1192R-transformants at the restrictive
temperature, without success (Fig. 8A and B). However, from our
results in Vero and COS-7 cells, we had the indication that
pP1192R is a strictly cytoplasmic protein. Seeing as in yeast cells
Top2p is a nuclear protein and its substrate (the DNA) is also
located in the nucleus, and because the yeast nuclear envelope
remains intact during cell division (Arnone et al., 2013), we
hypothesized that the absence of functional complementation of
yeast cells could simply be due to the impossibility of pP1192R to
act upon the yeast DNA. Top2p has been extensively studied and
its nuclear localization signals have been well characterized and
shown to be present in the C-terminal domain (Caron et al., 1994;
Jensen et al., 1996). Therefore, we fused pP1192R with the Top2p
C-terminal domain (from amino acid position 1189 to position
1428 of Top2p), expecting that we could force pP1192R to enter
the nucleus of the yeast cells. This was conﬁrmed by ﬂuorescence
microscopy, since in cells expressing GFP-pP1192R fused with the
Top2p C-terminal domain, the fusion protein is indeed present in
the nucleus (Fig. 8C), while in cells expressing GFP-pP1192R this
protein is localized solely in the cytoplasm and GFP alone is seen
having both nuclear and cytoplasmic localization. Consequently,
we checked again for functional complementation and found that
the pP1192R-Top2Cterm fusion protein does indeed rescue a top2
ts mutation (Fig. 8A and B), and similar results were observed
when we used another top2 ts strain, SD117 (Wasserman et al.,
1993) (not shown). The rescue was more evident in liquid cultures,
in which we observed that expression of pP1192R fused with the
C-terminal domain of Top2p in cells grown at the restrictive
temperature would allow for growth, while cells containing only
the empty expression vector, expressing the original pP1192R or
expressing just the Top2p C-terminal domain did not grow at the
restrictive temperature. To further substantiate the function of
pP1192R as a type II topoisomerase, we mutated (in the pP1192R
fused with the C-terminal of Top2p chimera) the predicted
catalytic residue, a tyrosine at position 800, to a phenylalanine
in order to abolish its activity and, thus, the rescue of the JCW26
strain at the restrictive temperature. Our results, both in solid and
in liquid media, conﬁrm our expectations, since no rescue was
observed for the catalytic mutant (Fig. 8A and B), and corroborate
that the predicted catalytic residue is indeed functional.
Nevertheless, it could still be argued that pP1192R was only
active because it was fused to the C-terminal domain of the yeast
Top2p, and that activity of pP1192R remained to be demonstrated.
Since topoII in vitro activity assays are usually performed at 37 1C,
and because the thermo-sensitive Top2p from yeast strain JCW26
should not be functional at this temperature, we assessed for
pP1192R activity in total yeast extracts of JCW26 transformants.
This was performed through a decatenation assay, as type II
topoisomerases are unique in their ability to catalyze the decate-
nation of double-stranded DNA molecules. In this assay, kineto-
plast DNA (kDNA) from Crithidia fasciculata is used, since it forms a
large network of catenated minicircles of DNA. In this form the
catenated circles are unable to enter and migrate in an agarose gel,
whereas upon decatenation the free circles migrate and can be
observed in two distinct forms, either open circular DNA or
covalently closed circular DNA. We thus tested increasing amounts
of total extracts of JCW26 cells expressing pP1192R, a pP1192R
catalytic mutant, the pP1192R-Top2pCterm fusion or the wild-type
Top2p, as conﬁrmed by SDS-PAGE (not shown), and observed that
pP1192R was able to decatenate kDNA as efﬁciently as wild-type
Top2p (Fig. 9). Also, and corroborating previously described
results, mutation of the predicted catalytic residue fully abrogated
the activity of pP1192R. The observed activities were all ATP-
dependent, as expected for type II DNA topoisomerases.
Discussion
In this study we analyzed the L60 type II topoisomerase P1192R
and found that several conserved motifs, present in prokaryotic and
especially in eukaryotic type II topoisomerases, are present in
P1192R but the less-conserved C-terminal domain is absent
(Fig. 1). The importance of the C-terminal domain in enzymatic
regulation has been previously reported, with sites and motifs
present in this domain being responsible for regulating protein
localization (Caron et al., 1994; Jensen et al., 1996; Mirski et al.,
2003, 1999), DNA-binding (Gilroy and Austin, 2011) and activity
(Meczes et al., 2008). Still, the C-terminal domain is also absent
from some previously described type II topoisomerases, as in the
case of topoII from Chlorella viruses, and these have been shown to
have high DNA cleavage activity (Dickey et al., 2005; Fortune et al.,
2001). Therefore, although it may be important, the C-terminal
domain is not a requirement for enzymatic activity. In fact, the
known type II topoisomerases that do not contain a C-terminal
domain are virally encoded, by NCLDV, which suggests that the
regulation occurring at the level of this domain may be of
importance for when there are reduced copies of the genetic
material, as in the case of prokaryotic or eukaryotic cells. In the
cases of viruses, in which there are many copies of the genome
waiting to be processed by the DNA topoisomerase II, these are
probably required to have high levels of activity (as seen for the
Chlorella viruses topoII) and the presence of the C-terminal domain
could somehow diminish this activity by making the enzymes
vulnerable to regulation like in their cellular counterparts.
Our phylogenetic analysis of P1192R showed it to be highly
conserved among the 14 ASFV isolates studied (Fig. 2), but quite
distinct from other known type II topoisomerases (Figs. 3 and 4).
This implies that this protein either arose independently by action
of convergent evolution or has evolved very rapidly, obscuring the
determination of an eventual last common ancestor. If the selec-
tive pressure to which the protein (and thus its DNA sequence) is
subjected is somewhat relaxed, it may allow a considerable level of
variation in its sequence, when compared to other known type II
topoisomerases, but still retaining the necessary motifs and
organization required for function. However, the high degree of
conservation among the ASFV pP1192R sequences suggests that a
Fig. 9. Decatenation activity in vitro assay. Yeast strain JCW26 was transformed
with pYES2, pYES2-P1192R, pYES2-P1192R Y800F, pYES2-P1192R-TOP2Cterm or
pYES2-TOP2. After induced expression of the respective recombinant proteins over
a 22-hour period, total yeast extracts were prepared and increasing amounts (0.1,
0.25, 0.5, 1.0 and 2.0 ml) of each extract were tested in an assay using kinetoplast
DNA as substrate. A representative image of two independent experiments
is shown.
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strong selective pressure maintains the amino acid sequence fairly
identical, perhaps due to an essential role of this protein in the
viral cycle.
A pairwise alignment of the L60 pP1192R and the yeast Top2p
(Supplementary ﬁle 2) revealed that they are only 21.6% identical
(335 identical amino acid residues), with a similarity of 35.6% (551
amino acid residues). Therefore, we were expecting to obtain only
a partial rescue of the mutant phenotype, as was the case (Fig. 8).
We also observed a slight reduction in the growth of yeast cells
expressing pP1192R fused with the C-terminal domain of Top2p at
the permissive temperature (not shown), suggesting that either
expression of this protein in high quantities is toxic for the cell, or
the presence of the viral protein in the cell nucleus may hinder the
activity of Top2p, perhaps through the formation of less-functional
heterodimers. Likewise, we cannot fully explain the difference
between rescue in cells grown in plates and in liquid media. In
liquid media the nutrients surround the cells and are, therefore,
readily available for uptake, while in solid media their uptake is
conditioned, especially after several cell divisions, and this may
certainly inﬂuence cellular growth rate. Also, it takes 24–48 h for
wild-type cells to form colonies in solid media. Since the pP1192R-
Top2pCterm-expressing cells already present a reduction in
growth, the combination of these factors may explain the differ-
ence observed between rescue in solid and in liquid media.
When testing for pP1192R activity in the decatenation assay we
found that the highest volume of extract used would result in an
accumulation of a considerable amount of kDNA in the well of the
agarose gel (Fig. 9, lane 10). Even though this could appear to be a
result of lack of activity, to which the contents of the total extract
could have somehow contributed, it is also possible that this is a
result of excess of activity. It has been described that high
concentrations of topoII may catalyze the catenation of circular
DNA molecules, mimicking lack of activity (Nitiss et al., 2012).
Interestingly, the pP1192R-Top2pCterm fusion protein seems to be
less functional than the wild-type pP1192R. This could be due to
structural instability of pP1192R caused by the addition of the
Top2p C-terminal domain, regulation of pP1192R activity via the
added C-terminal domain, or formation of less-functional hetero-
dimers as hypothesized above. Nevertheless, this does not impact
on the conclusions concerning the wild-type pP1192R.
Our indications that the activity observed in the in vitro
decatenation assay is of a type II DNA topoisomerase are two-
fold: ﬁrst, this class of enzymes requires ATP to function and
activity is not observed when ATP is omitted from the reaction
buffer; second, total extracts of JCW26 transformed with the
empty pYES2 vector provide the background level of DNA and
RNA contamination from the extract as well as residual decatena-
tion activity from the endogenous temperature-sensitive Top2p
enzyme or activities from other DNA-acting enzymes, and there is
a clear difference between these lanes and those in which
decatenation is observed. It is of relevance to consider that,
according to the supplier of the kinetoplast DNA, the kDNA used
in the assay generally contains some level of open circular (nicked)
DNA, with the nicking not being caused by the tested topoII, but,
despite that, a topoisomerase I cannot decatenate the network of
catenated minicircles.
Although P1192R was identiﬁed as having homology to type II
topoisomerases (Baylis et al., 1992; García-Beato et al., 1992) and it
has been suggested that type II topoisomerase-inhibiting drugs
have an effect on ASFV (Mottola et al., 2013; Salas et al., 1983),
proof of pP1192R functionality remained unaddressed. Heterolo-
gous expression of P1192R using either prokaryotic or eukaryotic
systems had been proposed and/or attempted by different
research groups but, to our knowledge, the proteins obtained have
never been shown to possess type II DNA topoisomerase activity.
In this work, we demonstrate that P1192R indeed codes for a
functional type II DNA topoisomerase, even if its precise role
during viral infection remains undetermined. Although previous
results (García-Beato et al., 1992) suggested that ORF P1192R is
transcribed prior to viral DNA replication, we could not detect viral
pP1192R in the presence of AraC. Therefore, it is possible that this
protein does not participate in early replication steps, but a role in
transcription of late-expressed genes cannot be ruled out. Further-
more, since the protein accumulates at viral factories over time, it
is also possible that it is a structural protein. This hypothesis ﬁnds
support in the observation by Salas et al. (1983) that the RNA
synthesis activity detected from ASFV virions is reduced in a dose-
dependent manner by coumermycin A1, an inhibitor of type II
topoisomerases. pP1192R may also participate in genome segrega-
tion, by facilitating the separation of newly-replicated DNA mole-
cules, as recently suggested for the Mimivirus topoII (Chelikani
et al., 2014), or even be involved in the packaging of the viral
genome into the virion.
Conclusions
ASFV ORF P1192R codes for a protein with type II DNA
topoisomerase activity. At intermediate to late phases of infection,
pP1192R is detected in the cytoplasm and co-localizing with the
viral factories. Its amino acid sequence is highly conserved among
different ASFV isolates but divergent when compared with other
type II DNA topoisomerases, though maintaining the necessary
motifs and domains required for this speciﬁc activity.
Materials and methods
Cells
Vero E6 (ECACC) and COS-7 CRL-1651 (ATCC) cell lines were
grown at 37 1C under a 5% CO2 atmosphere saturated with water
vapor in Dulbecco's Modiﬁed Eagle Medium (DMEM) with 4.5 g/l
Glucose, 0.11 g/l Sodium Pyruvate and 2 mM L-gluthamine, sup-
plemented with 10% (v/v) inactivated fetal bovine serum, penicil-
lin/streptomycin (100 units/ml and 100 mg/ml, respectively) and
nonessential amino acids (all from Gibco, Life Technologies).
Pig macrophages were obtained as previously described
(Portugal et al., 2009). Brieﬂy, heparinized blood samples from
crossbred Large White  Landrace pigs (6-month old), conﬁrmed
free of PRRS, mycoplasma and parvovirus, were obtained in aseptic
conditions during bleeding at the abattoir. Samples were incu-
bated at 37 1C for 15 min with 10% (v/v) of a 5% (v/v) Dextran T500
solution in Hank's balanced saline solution. Supernatants were
collected, diluted 1:1 in culture medium (RPMI 1640 with 100
units/ml penicillin, 100 mg/ml streptomycin, 20 mM HEPES), and
seeded (100 ml/ﬂask) in T175 tissue culture ﬂasks. Cultures were
incubated at 37 1C for 48 h, and non-adherent cells were removed
by extensive washing in pre-warmed PBS.
Viruses
ASFV isolates used were the highly virulent ASFV/L60 (Leitão
et al., 2001) (L60) and the Vero-adapted ASFV/Ba71V (Yáñez et al.,
1995) (Ba71V). L60 or Ba71V suspensions, puriﬁed as described in
(Leitão et al., 2000), were titrated by observation of cytopathic
effect at end-point dilutions in Vero monolayers or macrophage
cultures, respectively, and expressed as 50% tissue culture infec-
tious dose (TCID50).
Puriﬁed Ba71V or L60 were added to Vero/COS-7 cells or pig
macrophages, respectively, at the indicated multiplicities of infec-
tion, and after 1 h of adsorption at 37 1C the inoculum with the
J. Coelho et al. / Virology 474 (2015) 82–93 89
non-adsorbed virus was removed and the cells were washed with
serum-free medium and further incubated with complete culture
medium up to the indicated time periods.
Genomic DNA of isolate ASFV/E75 (De Villiers et al., 2010)
(E75), kindly provided by Dr. Carmina Gallardo, was used for
sequencing of ORF P1192R.
Electroporation
In order to transfect COS-7 cells, sub-conﬂuent monolayers
were harvested by trypsinization, washed twice with cold PBS and
resuspended in ice-cold electroporation buffer (120 mM KCl,
10 mM KH2PO4, 10 mM K2HPO4, 2 mM EGTA, 5 mM MgCl2,
25 mM HEPES, 0.15 mM CaCl2, pH 7.4). Per electroporation,
300 ml of the cell suspension was mixed with 30 mg of plasmid
DNA, the mix was transferred to a 0.2 cm electroporation cuvette
and incubated for 10 min on ice. Each cuvette was subjected to a
pulse of 700 V and 50 mF capacitance (using a Gene Pulser II
electroporator, Bio-Rad), followed by a brief period on ice until the
addition of complete culture medium, to resuspend the cells.
These were then plated on 24-well tissue culture plates, at the
desired cell density.
Immunoﬂuorescence
Monolayers of Vero or COS-7 cells grown in 24-well tissue
culture plates, at 1105 viable cells per well, were inoculated with
Ba71V, at a multiplicity of infection of 2. Where indicated, the cells
were incubated with 20 ng/ml of leptomycin B (Sigma-Aldrich)
in complete culture medium for 3 h prior to ﬁxation, or with
50 mg/mL of cytosine arabinoside (Sigma-Aldrich) in complete
culture medium for 4 h or 16 h prior to ﬁxation. Adherent macro-
phages were harvested after incubation with cold 0.8 mM EDTA in
PBS, washed with PBS, and plated at 1.5105 cells per well,
allowed to adhere for 3 h, and washed again to remove non-
adherent cells. They were then inoculated with L60, at a multi-
plicity of infection of 2.
Cells were then washed twice with PBS and ﬁxed with a 3.7%
(w/v) paraformaldehyde solution (in PBS) for 10 min, with slight
agitation. After two ﬁve-minutes washes with PBS, cells were
permeabilized with PBS containing 0.1% (w/v) Triton X-100 for
2 min, washed again twice with PBS for 5 min and ﬁnally washed
with PBS containing 0.1% (w/v) Tween 20. Cells were then blocked
with PBS containing 3% (w/v) BSA (blocking solution) for 30 min,
after which they were incubated for 1 hour with the primary
antibody(ies). Two washes with PBS and one with PBS containing
0.1% (v/v) Tween 20 followed, as did a one-hour incubation with
the secondary antibody(ies). Finally, coverslides were washed
twice with PBS for 10 min before being mounted in DAPI-
containing VECTASHIELD (Vector Laboratories). All the incubations
described above were performed at room temperature.
The primary antibodies used were a mouse polyclonal antibody
raised against the recombinant full-length pP1192R, produced in S.
cerevisiae, an in-house swine anti-ASFV whole-serum, an anti-
VP32 antiserum kindly provided by Dr. Michael Parkhouse, Insti-
tuto Gulbenkian de Ciência, a commercial anti-VP72 antibody
(M.11.PPA.I1BC11, Ingenasa), and a commercial anti-NF-κB p65
rabbit polyclonal antibody (sc-7151, Santa Cruz Biotechnology),
used at 1:1000, 1:500, 1:50, 1:50 and 1:100 dilutions, respectively.
The conjugated secondary antibodies were the following: anti-pig-
FITC IgG (ab6773, Abcam), anti-pig-TexasRed IgG (ab6775, Abcam)
and anti-mouse-Cy3 IgG (A10521, Life Technologies), all at 1:500,
and anti-rabbit-AlexaFluor 647 IgG (A-21244, Life Technologies), at
1:200. All dilutions of primary and secondary antibodies were
performed in blocking solution. Images were acquired on a Leica
DMRA2 upright microscope, equipped with a CoolSNAP HQ CCD
camera.
Cloning and sequencing of P1192R from ASFV/L60
L60 genomic DNA was obtained from infected pig macrophages
and isolated using a High Pure Viral Nucleic Acid Kit (Roche). The
complete ORF P1192R (skipping the endogenous stop codon) was
then PCR-ampliﬁed using speciﬁc primers including NdeI and NotI
restriction sites, cloned in NdeI and NotI sites of the pET24a
expression vector (Novagen), and its sequence was determined
and deposited in GenBank.
For expression in COS-7 cells, P1192R was cloned in vector
pIC113 (Cheeseman and Desai, 2005) in frame with the existing
GFP ORF, allowing the construction of an N-terminal GFP-P1192R
fusion under the control of the human cytomegalovirus immediate
early promoter. For cloning in this plasmid, P1192R was PCR-
ampliﬁed (without the endogenous ATG) with primers including
sites for BspEI and KpnI and cloned in pIC113 using these enzymes.
To obtain the mutant versions of P1192R, without the putative
nuclear localization sequence (NLS) or the putative nuclear export
sequence (NES), site-directed mutagenesis was performed using
the QuikChange II XL Site-Directed Mutagenesis Kit (Agilent
Technologies), according to the manufacturer's instructions, incl-
uding the primer design. Creation of the NLS mutant implied the
deletion of nucleotides 877–897, while for the NES mutant the
deleted nucleotides were from 1327 to 1356. In both cases, the
reading frame was maintained after the deletion.
To express P1192R in S. cerevisiae, the complete ORF P1192R
was PCR-ampliﬁed with the forward and reverse primers contain-
ing KpnI and NotI sites, respectively. The PCR fragment was
hydrolyzed and cloned in the KpnI and NotI sites of the yeast
expression vector pYES2 (Life Technologies). This originated plas-
mid pYES2-P1192R. To obtain the catalytic mutant in pYES2-
P1192R site-directed mutagenesis was performed using the Quik-
Change II XL Site-Directed Mutagenesis Kit (Agilent Technologies),
according to the manufacturer's instructions, including the primer
design. This implicated the mutation of an adenine at position
2399 to a thymine, originating a tyrosine to phenylalanine change
in the respective protein sequence.
To obtain a positive control for the complementation of the
temperature-sensitive yeast strains, the yeast endogenous wild
type TOP2 ORF, coding for the yeast type II topoisomerase, was
cloned in the pYES2 vector. For this, yeast genomic DNA was
extracted from strain BY4741 as described by Harju et al. (2004)
and the ORF TOP2 was PCR-ampliﬁed (skipping the endogenous
stop codon) using primers with built-in BamHI and XhoI sites and
cloned in the pET24a vector, in-frame with the present 6His tag,
using these two enzymes. The same forward primer in combina-
tion with a new reverse primer, with a NotI site, were used for PCR
ampliﬁcation of the TOP2-6His ORF, which was cloned in pYES2,
originating the plasmid pYES2-TOP2.
For the construction of the P1192R-TOP2C-terminal fusion pro-
tein, the ORF P1192R was PCR-ampliﬁed, skipping the endogenous
stop codon, and cloned in plasmid pPICZαC (Life Technologies),
previously hydrolyzed with the same restriction enzymes, in-frame
with the existent 6xHis tag. Using the same forward primer in
combination with a new speciﬁc reverse primer, with a NotI site, the
P1192R-6xHis ORF was PCR ampliﬁed and cloned in vector pYES2,
originating plasmid pYES2-P1192R_6xHis. Further hydrolysis of this
plasmid with NotI resulted in the excision of the 6xHis tag, since it
was located between NotI sites. Then, the TOP2 C-terminal region
(nucleotides 3543–4287) was ampliﬁed using primers containing
NotI sites and cloned in frame with P1192R in plasmid pYES2-
P1192R-6xHis after its digestion with NotI, thereby substituting the
6xHis tag and originating plasmid pYES2-P1192R-TOP2Cterm. The
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catalytic mutant in pYES2-P1192R-TOP2Cterm was obtained as
described above for pYES2-P1192R.
For the cloning of the TOP2 C-terminal region in pYES2, to use
as a negative control, the respective fragment (obtained as
described above) was cloned in a NotI-hydrolyzed pYES2 vector,
originating plasmid pYES2-TOP2Cterm.
For the analysis of the cellular localization of pP1192R and
pP1192R-Top2Cterm, the GFP ORF from pIC113 was ampliﬁed by
PCR using primers containing KpnI sites, hydrolyzed with this
restriction enzyme and cloned in KpnI-hydrolyzed plasmids
pYES2, pYES2-P1192R or pYES2-P1192R-TOP2Cterm, respectively.
Bioinformatic analysis of P1192R and other type II topoisomerases
Deﬁnition of domains in type II topoisomerases was performed
using the InterProScan resource available at http://www.ebi.ac.uk/
Tools/pfa/iprscan/. Search for conserved motifs in the P1192R
deduced amino acid sequence was carried out with the use of
patmatdb and pairwise alignments of type II topoisomerases were
done using needle, both of which are EMBOSS tools (Rice et al.,
2000). The presence of nuclear localization signals was predicted
using the PSORT II program (Nakai and Horton, 1999) and NetNES
v1.1 (La Cour et al., 2004) was used for nuclear export signal
prediction.
Sequence alignment and phylogenetic analysis
DNA sequences of ORF P1192R were obtained from sequencing
(L60 and E75), from personal communication by R. Portugal and G.
Keil (ASFV/NH/P68) or retrieved from ASFV genomic sequences
available at the Asfarviridae Bioinformatics Resource (http://
athena.bioc.uvic.ca/organisms/Asfarviridae) or from GenBank
(Ba71V, NC_001659.1; ASFV/Benin97/1, AM712239.1; ASFV/
OURT88/3, AM712240.1; E75, FN557520.1; ASFV/Mkuzi1979,
AY261362.1; ASFV/Georgia2007/1, FR682468.1; ASFV/Tengani62,
AY261364.1; ASFV/Pretorisuskop96/4, AY261363.1; ASFV/Warthog,
AY261366.1; ASFV/Warmbaths, AY261365.1; ASFV/Malawi Lil/20/1,
AY261361.1; ASFV/Kenya1950, AY261360.1). Sequences of ASFV
proteins were obtained through in silico translation of the respec-
tive nucleotide sequences, and used in protein-protein BLAST
searches (with a threshold of 0.0001 and remaining options as
default) performed against the UniProtKB database (http://www.
uniprot.org). Protein sequences obtained from BLAST searches
and used for multiple sequence alignments are indicated in
Supplementary ﬁle 3. For comparison, the sequences of the three
subunits of the phage T4 type II topoisomerase were merged in a
single sequence, as were sequences of gyraseB and gyraseA of E.
coli or M. tuberculosis. The alignments were performed using M-
COFFEE (Moretti et al., 2007), while DNA sequence alignments
were done using CLUSTALW2 (Larkin et al., 2007), available at
http://www.ebi.ac.uk/Tools/msa/clustalw2/ (Goujon et al., 2010),
both with default parameters. TrimAl (Capella-Gutiérrez et al.,
2009) was used for protein alignment curation, with most default
settings, but choosing a gap threshold (fraction of positions with-
out gaps in a column) of 0.8 and a minimum percentage of
positions to conserve of 20. ProtTest 3.0 (Darriba et al., 2011)
and jModelTest 2.1.2 (Darriba et al., 2012) were used to select the
best model for phylogenetic tree construction based on protein
and DNA alignments, respectively. Maximum likelihood (ML) trees
were constructed using PhyML 3.0 (Guindon et al., 2010) with
1000 (when possible) or 100 bootstrap replicates, using settings
indicated by previous determination of the best phylogenetic
model. Trees were edited using the program MEGA 5 (Tamura
et al., 2011).
Yeast strains
S. cerevisiae strains used in this work were JCW26, SD117
(Wasserman et al., 1993), kindly provided by Dr. C. Austin, New-
castle University, and BY4741 (Brachmann et al., 1998), kindly
provided by Dr. L. Cyrne, University of Lisbon. When untrans-
formed, these strains were kept and grown at 25 1C on solid or
liquid YPD medium, containing 2% (w/v) glucose. When trans-
formed, as described by Ito et al. (1983), and unless stated
otherwise, the strains were grown at 25 1C on solid or in liquid
casamino acid (CAA) medium without uracil and containing
2% (w/v) glucose.
Yeast complementation assays
To carry out complementation assays in solid medium, yeast
cells from stationary phase CAA without uracil cultures, with 2%
(w/v) rafﬁnose as the carbon source, were collected by centrifuga-
tion and resuspended in a previously sterilized solution containing
10 mM Tris–HCl (pH 7.5) and 5 mM EDTA, and cell density was
adjusted to an OD600 of 3. From this suspension, serial three-fold
dilutions were prepared and 3 μl of each dilution were spotted on
freshly prepared solid YPD medium with either 2% (w/v) glucose
or 2% (w/v) galactose as the carbon source. The plates were
incubated for 5 days at 25 1C or 35 1C.
For the complementation assays in liquid medium, yeast cells
from stationary phase CAA without uracil cultures, with 2% (w/v)
rafﬁnose as the carbon source, were used to inoculate new CAA
without uracil cultures, with 2% (w/v) galactose as the carbon
source, at an OD600 of 0.1. These cultures were split in half, with
one half being incubated for 24 h at 25 1C while the other was
incubated for the same time period at 35 1C. Samples for the
cultures were collected at the indicated time points for determi-
nation of their growth curves.
Fluorescence microscopy of yeast
Cells in stationary phase from CAAwithout uracil cultures, with
2% (w/v) rafﬁnose as the carbon source, were used to inoculate
new CAA without uracil cultures, with 2% (w/v) galactose as the
carbon source, at an OD600 of 0.5. After 16 h of incubation at 25 1C,
450 ml of each were collected and to each 50 μl of formol (36.5%
formaldehyde, 10% methanol) were added. After 10 min of incuba-
tion at room temperature cells from these formaldehyde contain-
ing suspensions were collected by centrifugation and the pellets
were resuspended in 1 ml PBS containing 10% (v/v) formol. After
6 h of incubation at room temperature cells were collected by
centrifugation, washed three times with PBS and incubated with
1 mg/ml DAPI (Sigma-Aldrich) for 10 min. Equal volumes of each
suspension and of Fluoromount-G (SouthernBiotech) were mixed
and 5 ml of that mixture were used to prepare samples for
visualization. Cells were visualized on a Leica DMRA2 upright
microscope, equipped with a CoolSNAP HQ CCD camera.
Expression and puriﬁcation of full-length recombinant pP1192R in
S cerevisiae
S. cerevisiae strain BY4741, harboring the recombinant pYES2-
P1192R_6xHis plasmid, was grown in CAA medium without uracil
to an OD600 of 1 and induction was carried out by addition of
galactose to a ﬁnal concentration of 6% (w/v) for 24 h, at 25 1C.
Cells were then harvested by centrifugation, washed with sterile
H2O and the pellet was resuspended in buffer A (50 mM Tris–HCl
pH 8.0, 1 M NaCl, 10% (v/v) glycerol, and 1 mM PMSF). About half
the volume of acid-washed glass beads (G8772, Sigma-Aldrich)
was added, and a single 30-minute cycle of vortexing was performed,
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while adding 0.1 mM PSMF every 5 min. The supernatant was
collected, the beads washed with buffer A and both supernatants
were pooled and centrifuged for 30 min at 15,000 g, followed by
ﬁltration using a 0.45 mm ﬁlter. The extract was then mixed with
0.2 volumes of buffer B (50 mM Tris–HCl pH 8.0, 1 M NaCl, 10% (v/v)
glycerol, 250 mM imidazole, and 10 mM beta-mercaptoethanol) and
the mixture was incubated with Ni Sepharose 6 Fast Flow slurry (GE
Healthcare) for about 3 h. The mixture was loaded onto a PD-10
column (GE Healthcare), washed sequentially with a combination of
buffers A and B (8%, 20% and 30% buffer B), and elution was
performed using only buffer B. Fractions were collected in low-
binding tubes, analyzed by SDS-PAGE and either immediately used
for downstream applications or stored at 80 1C until further use.
Preparation of total yeast extracts
Cells from S. cerevisiae strain JCW26 containing plasmid pYES,
pYES2-P1192R, pYES2-P1192R Y800F, pYES2-P1192R-TOP2Cterm
or pYES2-TOP2, were grown in CAA medium without uracil,
containing 2% (w/v) rafﬁnose as the carbon source, to an OD600
of 0.4 and induction was carried out by addition of galactose to a
ﬁnal concentration of 2% (w/v) for 22 h, at 25 1C. Cells were then
harvested by centrifugation and each cell pellet was resuspended
in lysis buffer (50 mM Tris–HCl, pH 7.5, 500 mM KCl, 10% (v/v)
glycerol, 1 mM EDTA, 10 mM (NH4)2SO4, 0.1% (w/v) Triton X-100,
1 mM DTT, and 1 mM PSMF), with the volume of lysis buffer
depending on the cell culture density at the time of collection, and
about half the volume of acid-washed glass beads was added. After
a single 30-minute cycle of vortexing, with the addition of 0.1 mM
PSMF every 10 min, each suspension was subjected twice to 1 min
of sonication. From each suspension 1 ml was collected and
centrifuged at 16,000 g for 10 min, 4 1C, and the supernatants
were saved. For enzymatic assays different amounts of super-
natant were used.
Assay of type II DNA topoisomerase activity
Decatenation activity of type II DNA topoisomerase was tested
by using kinetoplast DNA (TopoGEN) from C. fasciculata. Reactions
were carried out for 1 h at 37 1C in a total of 20 ml of reaction buffer
(50 mM Tris–HCl, pH 7.5, 20 mM NaCl, 20 mM MgCl2, 0.5 mM
EDTA, 0.5 mM DTT, and 150 ng kDNA), with or without 2 mM ATP
(Sigma-Aldrich). Reactions were stopped by addition of 4 ml of stop
solution (5% (v/v) sarkosyl, 0.003% (w/v) bromophenol blue, and
25% (v/v) glycerol) and electrophoresed in a 0.8% (w/v) agarose gel,
with TAE buffer (40 mM Tris-Acetate and 1mM EDTA), for 2 h.
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